A whole-brain functional connectivity model of Alzheimer's disease pathology
- PMID: 39711458
- PMCID: PMC11781256
- DOI: 10.1002/alz.14349
A whole-brain functional connectivity model of Alzheimer's disease pathology
Abstract
Introduction: Alzheimer's disease (AD) is characterized by the presence of two proteinopathies, amyloid and tau, which have a cascading effect on the functional and structural organization of the brain.
Methods: In this study, we used a supervised machine learning technique to build a model of functional connections that predicts cerebrospinal fluid (CSF) p-tau/Aβ42 (the PATH-fc model). Resting-state functional magnetic resonance imaging (fMRI) data from 289 older adults in the Alzheimer's Disease Neuroimaging Initiative (ADNI) were utilized for this model.
Results: We successfully derived the PATH-fc model to predict the ratio of p-tau/Aβ42 as well as cognitive functioning in older adults across the spectrum of healthy and pathological aging. However, the in-sample fit magnitude was low, indicating a need for further model development.
Discussion: Our pathology-based model of functional connectivity included representation from multiple canonical networks of the brain with intra-network connectivity associated with low pathology and inter-network connectivity associated with higher levels of pathology.
Highlights: Whole-brain functional connectivity model (PATH-fc) is linked to AD pathophysiology. The PATH-fc model predicts performance in multiple domains of cognitive functioning. The PATH-fc model is a distributed model including representation from all canonical networks.
Keywords: cognition; connectome‐based predictive modeling; distributed networks; functional connectivity; resting‐state.
© 2024 The Author(s). Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Conflict of interest statement
Author disclosures are available in the Supporting Information.
Figures



References
-
- Sperling RA, Aisen PS, Beckett LA, et al. Toward defining the preclinical stages of Alzheimer's disease: recommendations from the national institute on aging‐Alzheimer's association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011;7(3):280‐292. doi:10.1016/j.jalz.2011.03.003 - DOI - PMC - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical